Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities
Net (loss) income	$ (199,059)	$ 68,117
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	20,812	20,843
Amortization of deferred financing costs	5,136	3,144
Bad debt and sales return reserve	(252)	41
Goodwill impairment	311,114	0
Stock-based compensation expense	5,958	6,406
Excess tax benefit related to stock-based incentive plans	0	(796)
Deferred income taxes	(62,231)	4,240
Other non-cash items	528	(4,374)
Changes in assets and liabilities:
Accounts receivable	(15,972)	(10,466)
Inventories	(91,599)	(25,253)
Prepaid expenses and other assets	(1,854)	(352)
Income taxes receivable	86	5
Accounts payable	(5,675)	21,466
Accrued expenses and other liabilities	6,905	(6,098)
Income taxes payable	(6,743)	(10,330)
Net cash (used in) provided by operating activities	(32,846)	66,593
Cash flows from investing activities
Purchase of property and equipment	(6,831)	(11,161)
Proceeds from sales of assets	0	2,000
Net cash used in investing activities	(6,831)	(9,161)
Cash flows from financing activities
Proceeds from short-term borrowings	60,000	0
Repayment of short-term borrowings	(12,000)	0
Repayment of long-term debt	(16,344)	(76,000)
Financing costs	(12,796)	(2,126)
Repayment of capital lease obligations	(1,278)	(1,037)
Excess tax benefit related to stock-based incentive plans	0	796
Proceeds from issuance of common stock	2,965	6,126
Settlement on restricted stock tax withholding	(264)	0
Net cash provided by (used in) financing activities	20,283	(72,241)
Effect of foreign currency exchange rate on cash and cash equivalents	(611)	(2,572)
Net decrease in cash and cash equivalents	(20,005)	(17,381)
Cash and cash equivalents, beginning of period	77,061	82,866
Cash and cash equivalents, end of period	$ 57,056	$ 65,485